Thermo Fisher Bioproduction Insights

  1. Evaluation Of AOF Peptones To Enhance Viral Vector Vaccine Production 5/10/2024

    Explore the results of a study analyzing the use of peptones to improve the viral vector production process by enhancing cell growth.

  2. Effect Of AOF Peptone Supplementation In Batch And Fed Batch Modes 5/10/2024

    This study focuses on AOF peptones and their impact on cell density, viability, and mAb titers, with results suggesting that peptones can enhance mAb titers.

  3. Animal-Origin Free Peptones Enhance Adenovirus Production 5/10/2024

    This study evaluates the use of AOF peptones in the production of the adenoviral vector used in vaccine delivery and gene therapy.

  4. The Value Of Premium Gibco Peptones 5/10/2024

    Achieve the optimal nutritional balance with diverse supplements tailored for your specific bioprocess that can be added to maintain a nutritionally balanced medium.

  5. Explore A High-Performing Basal Medium And Feed Pairing 5/8/2024

    A customer sought to replace a chemically defined CHO medium with a more efficient medium and feed pairing strategy in bioreactors.

  6. Buffers And Process Liquids For Biopharmaceutical Production: Considerations For Scale-Up And Outsourcing 5/7/2024

    For small and midsize biopharmaceutical organizations, outsourcing buffer and process liquid preparation, quality testing, and storage could significantly streamline operations and reduce regulatory risk.

  7. Advancing Cell Therapy Manufacturing: Rapid Sterility Testing 5/7/2024

    The rapid sterility test kit used in the study was able to quickly detect bacteria and fungi in complex cell therapy product matrices, detecting six species listed in USP chapter <71>.

  8. Screening Peptones, Including "Titration And Blending" Protocol Examples 5/3/2024

    Dive into the importance of peptone selection, instructions for reconstituting peptone powders for mammalian cell culture, and discover starter packs containing commonly used peptones for specific applications.

  9. Enabling CDMOs To Focus On Core Priorities 4/26/2024

    Explore innovative solutions for CDMO's striving to remain competitive as the biopharmaceutical market grows and evolves.

  10. Accelerating SARS-CoV-2 Immunotherapy Speed To Clinic 4/26/2024

    A clinical-stage biotherapeutics company developing a COVID-19 immunotherapy searched for a solution to the difficulties it faced in scaling up its manufacturing operations due to limited resources.